期刊文献+

Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it? 被引量:10

Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
下载PDF
导出
摘要 Surveillance for hepatocellular carcinoma(HCC)is considered a standard of care for patients with chronic liver disease who are at risk of developing this malignancy.Several studies have shown that surveillance can improve the prognosis of patients diagnosed with HCC through an increased likelihood of application of curative or effective treatments.Repetition of liver ultrasonography(US)every 6 mo is the recommended surveillance program to detect early HCCs,and a positive US has to entrain a well-defined recall policy based on contrast-enhanced,dynamic radiological imaging or biopsy for the diagnosis of HCC.Although HCC fulfills the accepted criteria regarding cost-effective cancer screening and surveillance,the implementation of surveillance in clinical practice is defective and this has a negative impact on the cost-effectiveness of the procedure.Education of both physicians and patients is of paramount importance in order to improve the surveillance application and its benefits in patients at risk of HCC.The promotion of specific educational programs for practitioners,clinicians and patients is instrumental in order to expand the correct use of surveillance in clinical practice and eventually improve HCC prognosis. Surveillance for hepatocellular carcinoma (HCC) is considered a standard of care for patients with chronic liver disease who are at risk of developing this malignancy. Several studies have shown that surveillance can improve the prognosis of patients diagnosed with HCC through an increased likelihood of application of curative or effective treatments. Repetition of liver ultrasonography (US) every 6 mo is the recommended surveillance program to detect early HCCs, and a positive US has to entrain a well-defined recall policy based on contrast-enhanced, dynamic radiological imaging or biopsy for the diagnosis of HCC. Although HCC fulfills the accepted criteria regarding cost-effective cancer screening and surveillance, the implementation of surveillance in clinical practice is defective and this has a negative impact on the cost-effectiveness of the procedure. Education of both physicians and patients is of paramount importance in order to improve the surveillance application and its benefits in patients at risk of HCC. The promotion of specific educational programs for practitioners, clinicians and patients is instrumental in order to expand the correct use of surveillance in clinical practice and eventually improve HCC prognosis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第47期8808-8821,共14页 世界胃肠病学杂志(英文版)
关键词 HEPATOCELLULAR CARCINOMA SURVEILLANCE Screening ULTRASONOGRAPHY COST-EFFECTIVENESS Hepatocellular carcinoma, Surveillance, Screening, Ultrasonography, Cost-effectiveness
  • 相关文献

参考文献115

  • 1Hashem B. El-Serag,Abeer Alsarraj,Peter Richardson,Jessica A. Davila,Jennifer R. Kramer,Janet Durfee,Fasiha Kanwal.Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey[J]. Digestive Diseases and Sciences . 2013 (11)
  • 2Alessandro Cucchetti,Fabio Piscaglia,Matteo Cescon,Antonio Colecchia,Giorgio Ercolani,Luigi Bolondi,Antonio D. Pinna.Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma<!-- Doctopic: CAN -->[J]. Journal of Hepatology . 2013 (2)
  • 3N. A. Kennedy,A. Rodgers,R. Altus,R. McCormick,R. Wundke,A. J. Wigg.Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study[J]. Intern Med J . 2013 (7)
  • 4Kwang-Hyub Han,Do Young Kim,Jun Yong Park,Sang Hoon Ahn,Jieun Kim,Seung Up Kim,Ja Kyung Kim,Kwan Sik Lee,Chae Yoon Chon.Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study[J]. Journal of Clinical Gastroenterology . 2013 (6)
  • 5A. K. Singal,H. Salameh,Y.‐F. Kuo,R. J. Fontana.Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B[J]. Aliment Pharmacol Ther . 2013 (2)
  • 6Marzia Galassi,Massimo Iavarone,Sandro Rossi,Simona Bota,Sara Vavassori,Laura Rosa,Simona Leoni,Laura Venerandi,Sara Marinelli,Angelo Sangiovanni,Letizia Veronese,Mirella Fraquelli,Alessandro Granito,Rita Golfieri,Massimo Colombo,Luigi Bolondi,Fabio Piscaglia.Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound[J]. Liver Int . 2013 (5)
  • 7Yun‐Fan Liaw.Impact of therapy on the outcome of chronic hepatitis B[J]. Liver Int . 2013
  • 8Ana Paula Barreiros.Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines[J]. Journal of Hepatology . 2012 (4)
  • 9Eduardo Vilar Gomez,Yoan Sanchez Rodriguez,Luis Calzadilla Bertot,Ana Torres Gonzalez,Yadina Martinez Perez,Enrique Arus Soler,Ali Yasells Garcia,Luis Perez Blanco.The natural history of compensated HCV-related cirrhosis: A prospective long-term study[J]. Journal of Hepatology . 2012
  • 10Alessandro Cucchetti,Franco Trevisani,Matteo Cescon,Giorgio Ercolani,Fabio Farinati,Paolo Del Poggio,Gianludovico Rapaccini,Maria Anna Di Nolfo,Luisa Benvegnù,Marco Zoli,Franco Borzio,Edoardo Giovanni Giannini,Eugenio Caturelli,Maria Chiaramonte,Antonio Daniele Pinna.Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population[J]. Journal of Hepatology . 2012 (5)

二级参考文献31

  • 1Furusyo N, Hayashi J, Ohmiya M, Sawayama Y, Kawakami Y,Ariyama I, Kinukawa N, Kashiwagi S. Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection. Dig Dis Sci 1999; 44:608-617.
  • 2Kobayashi Y, WatanabeS, Konishi M, Yokoi M, Kakehashi R,Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Hepatology 1993;18:1319-1325.
  • 3Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323-325.
  • 4Tsolakos A, Zalatimo N. Hepatitis C: a review of diagnosis,management, and ocular complications from treatment. Optometru 2003: 74:517-523.
  • 5Chemello L, Bonetfi P, Cavalletto L, Talato F, Donadon V, CasarinP, Belussi F, Frezza M, Noventa F, Pontisso P. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group.Hepatology 1995; 22:700-706.
  • 6Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S,Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19:1088-1094.
  • 7Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C,Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V,Milotova V. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22:1050-1056.
  • 8Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type lb (Ⅱ) infection in France and Italy.Collaborative Study Group. Ann Intern Med 1995; 122:161-168.
  • 9Trimoulet P, Bernard PH, de Ledinghen V, Oui B, Chene G, Saint-Marc Girardin MF, Dantin S, Couzigou P, Fleury H. Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alvha. Die Dis Sci 2000; 45: 175-181.
  • 10Kao JH,Chen PJ, Lai MY, Wang TH, Chert DS. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: no correlation with viral genotypes 1b, 2a, and 2b. J Med Virol 1997; 52:270-274.

共引文献11

同被引文献65

引证文献10

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部